MarkWide Research

Sale!

Ambulatory Arrhythmia Monitoring Devices Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: December, 2022
No of Pages: 164
Delivery Format: PDF+ Excel

$2,950.00

Ambulatory Arrhythmia Monitoring Devices Market

1. Introduction

 

An ambulatory arrhythmia monitoring device is a medical device that is worn by a patient for a period of time, usually for 24 to 48 hours, to continuously monitor the patient’s heart rhythm. The device is usually connected to a portable recorder that the patient wears around their neck or waist. The recorder stores the data from the device and can be downloaded to a computer for analysis by a doctor.

 

There are several different types of ambulatory arrhythmia monitoring devices, including Holter monitors, event monitors, and loop recorders. Holter monitors are the most common type of device and are worn for 24 to 48 hours. Event monitors are worn for a longer period of time, usually for one to two months, and are activated when the patient feels a heart arrhythmia. Loop recorders are implanted under the skin and can be worn for up to one year.

 

Ambulatory arrhythmia monitoring is a useful tool for diagnosing and managing heart arrhythmias. The data from the device can help doctors to identify the type of arrhythmia and to determine the best treatment.

2. Types of Ambulatory Arrhythmia Monitoring Devices

 

An ambulatory arrhythmia monitoring device is a small, portable device that is worn on the body to continuously monitor heart rate and rhythm. There are two main types of ambulatory arrhythmia monitoring devices: Holter monitors and event monitors.

 

Holter monitors are worn for 24 to 48 hours and record the electrical activity of the heart during that time. The recordings are then sent to a doctor for interpretation. Event monitors are worn for longer periods of time, often for one to two months. They are used to record episodes of irregular heartbeats that occur sporadically. The recordings are also sent to a doctor for interpretation.

 

Ambulatory arrhythmia monitoring devices are used to diagnose and manage a variety of heart conditions, including arrhythmias, heart attacks, and congestive heart failure. They are also used to assess the effectiveness of treatments for heart conditions.

3. Market Size and Forecast

 

The global ambulatory arrhythmia monitoring devices market was valued at US$ 1,208.4 million in 2019 and is expected to grow at a CAGR of 7.2% from 2020 to 2027 to reach US$ 1,935.1 million by 2027.

 

Arrhythmia is a heart condition characterized by an irregular heartbeat. The heart may beat too fast, too slow, or with an irregular rhythm. Arrhythmia can be benign, but in some cases, it can lead to more serious conditions such as heart failure and stroke.

 

Ambulatory arrhythmia monitoring devices are used to detect and monitor arrhythmias. These devices are worn for a specified period of time, usually 24 to 48 hours, and can be worn while the patient goes about his/her daily activities.

 

The ambulatory arrhythmia monitoring devices market is driven by factors such as the increasing prevalence of arrhythmia and the rising number of geriatric population. In addition, the growing demand for minimally invasive arrhythmia treatment and the development of new technology are expected to drive the growth of the market in the coming years.

 

However, the high cost of these devices and the lack of awareness about these devices are expected to restraint the growth of the market.

 

The global ambulatory arrhythmia monitoring devices market is segmented by product, end user, and geography.

 

On the basis of product, the ambulatory arrhythmia monitoring devices market is categorized into event monitors, loop event monitors, and Holter monitors. The event monitors segment is expected to grow at the highest CAGR during the forecast period.

 

On the basis of end user, the ambulatory arrhythmia monitoring devices market is segmented into hospitals, clinics, and ambulatory surgical centers. The hospitals segment is expected to grow at the highest CAGR during the forecast period.

 

On the basis of geography, the ambulatory arrhythmia monitoring devices market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is expected to grow at the highest CAG

4. Market Drivers

 

The ambulatory arrhythmia monitoring devices market is primarily driven by the rising prevalence of cardiovascular diseases and the growing geriatric population. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for more than 17.9 million deaths in 2016. CVDs include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and congenital heart disease. The WHO estimates that the global prevalence of CVDs will increase to 23.6 million by 2030.

 

The growing geriatric population is another major driver of the ambulatory arrhythmia monitoring devices market. The aging population is more susceptible to chronic diseases such as CVDs, which is expected to drive the demand for ambulatory arrhythmia monitoring devices. According to the United Nations (UN), the global population aged 60 years or older is expected to grow from 962 million in 2017 to 2.1 billion by 2050.

 

The rising awareness of arrhythmias and the availability of technologically advanced ambulatory arrhythmia monitoring devices are also expected to drive the growth of the ambulatory arrhythmia monitoring devices market. In addition, the growing adoption of remote patient monitoring (RPM) systems is expected to boost the growth of the ambulatory arrhythmia monitoring devices market. RPM is a healthcare delivery model that uses information technology to collect patient data from a remote location and transmit it to a healthcare provider for analysis and interpretation.

5. Market Restraints

 

The Ambulatory Arrhythmia Monitoring Devices market is growing rapidly, but there are several restraints that are limiting its growth. Here are the five main market restraints:

 

1. Lack of awareness about arrhythmia and its symptoms: A large portion of the population is unaware of arrhythmia and its symptoms. This lack of awareness is a major restraint for the growth of the ambulatory arrhythmia monitoring devices market.

 

2. High cost of devices: The devices used for ambulatory arrhythmia monitoring are quite expensive. This high cost is a major restraint for the growth of the ambulatory arrhythmia monitoring devices market.

 

3. Lack of trained personnel: There is a lack of trained personnel who can effectively use ambulatory arrhythmia monitoring devices. This is a major restraint for the growth of the ambulatory arrhythmia monitoring devices market.

 

4. reimbursement issues: There are several reimbursement issues associated with ambulatory arrhythmia monitoring devices. These reimbursement issues are a major restraint for the growth of the ambulatory arrhythmia monitoring devices market.

 

5. Stringent regulations: There are several stringent regulations associated with the use of ambulatory arrhythmia monitoring devices. These regulations are a major restraint for the growth of the ambulatory arrhythmia monitoring devices market.

6. Market Opportunities

 

The arrhythmia monitoring devices market is growing rapidly with the rising prevalence of cardiovascular diseases and the growing number of geriatric population. According to a report by Allied Market Research, the global ambulatory arrhythmia monitoring devices market is expected to generate revenue of $2.16 billion by 2025, at a CAGR of 9.2% from 2018 to 2025.

 

There are various types of arrhythmia monitoring devices available in the market such as event monitors, Holter monitors, and implantable loop recorders. Event monitors are further classified into loop event monitors and ambulatory event monitors. Among these, event monitors held the largest market share in 2017 and is expected to grow at a CAGR of 9.0% during the forecast period.

 

The major players operating in the ambulatory arrhythmia monitoring devices market include Medtronic plc, Biotronik SE & Co. KG, Boston Scientific Corporation, Abbott Laboratories, Koninklijke Philips N.V., LivaNova PLC, and Cardiac Science Corporation.

 

The market is segmented based on product, type, end user, and geography. Based on product, the market is classified into event monitors, Holter monitors, and implantable loop recorders. On the basis of type, the market is divided into ambulatory event monitors and loop event monitors. By end user, it is categorized into hospitals, clinics, and home care settings. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

 

Key Market Segments

 

By Product

 

• Event Monitors

o Ambulatory Event Monitors

o Loop Event Monitors

• Holter Monitors

• Implantable Loop Recorders

 

By Type

 

• Ambulatory Event Monitors

• Loop Event Monitors

 

By End User

 

• Hospitals

• Clinics

• Home Care Settings

 

By Geography

 

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o

7. Key Players

 

An ambulatory arrhythmia monitor is a device that is worn on the body and used to detect and record heart rhythm abnormalities. These devices are used to diagnose and manage a variety of heart conditions, including arrhythmias, heart failure, and cardiomyopathies.

 

There are a variety of ambulatory arrhythmia monitors available on the market, each with its own unique features and benefits. Here are 7 of the key players in the ambulatory arrhythmia monitoring devices market:

 

1. CardioNet: CardioNet is a market leader in ambulatory cardiac monitoring, with over 20 years of experience. CardioNet offers a variety of ambulatory arrhythmia monitors, including the MCell, which is the only monitor that is FDA-approved for use in all 3 arrhythmia detecting modes: Holter, event, and loop recording.

 

2. LifeWatch AG: LifeWatch AG is a leading provider of remote cardiac monitoring services. LifeWatch offers a variety of ambulatory arrhythmia monitors, including the LifeWatch V-Monitor, which is the only monitor on the market that offers all 3 arrhythmia detecting modes in a single device.

 

3. eCardio Diagnostics: eCardio is a leading provider of ambulatory cardiac monitoring services. eCardio offers a variety of ambulatory arrhythmia monitors, including the eCardio Meridian, which is the only monitor on the market that offers all 3 arrhythmia detecting modes in a single device.

 

4. Zio by iRhythm: Zio by iRhythm is a leading provider of ambulatory cardiac monitoring services. Zio offers a variety of ambulatory arrhythmia monitors, including the Zio XT, which is the only monitor on the market that offers all 3 arrhythmia detecting modes in a single device.

 

5. BIOTRONIK Home Monitoring: BIOTRONIK Home Monitoring is a leading provider of ambulatory cardiac monitoring services. BIOTRONIK offers a variety of ambulatory arrhythmia monitors, including the BIOTRONIK Home Monitoring System,

8. Conclusion

 

The global ambulatory arrhythmia monitoring devices market is expected to reach USD 1.79 billion by 2025 from USD 1.17 billion in 2020, at a CAGR of 8.8%. The major factors driving the growth of this market are the rising prevalence of cardiovascular diseases and the growing preference for remote patient monitoring.

 

The key players in the ambulatory arrhythmia monitoring devices market are Boston Scientific Corporation (US), Medtronic plc (Ireland), Abbott Laboratories (US), Biotronik SE & Co. KG (Germany), Philips Healthcare (Netherlands), Cardionet, Inc. (US), and Zoll Medical Corporation (US).

 

The ambulatory arrhythmia monitoring devices market is segmented into event monitors, Holter monitors, and implantable loop recorders. The event monitors segment is expected to grow at the highest CAGR during the forecast period. The rising prevalence of cardiovascular diseases and the growing preference for remote patient monitoring are the major factors driving the growth of this segment.

 

The ambulatory arrhythmia monitoring devices market, by end user, is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories. The hospitals segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by the rising prevalence of cardiovascular diseases and the growing number of hospital admissions for arrhythmia treatment.

 

The ambulatory arrhythmia monitoring devices market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to grow at the highest CAGR during the forecast period. The growth of this market is driven by the rising prevalence of cardiovascular diseases, the growing number of hospital admissions for arrhythmia treatment, and the increasing number of ambulatory surgical centers in the region.

 

LIST OF KEY COMPANIES PROFILED:

 

    • Abbott (Lake Bluff, U.S.)
    • Medtronic (Dublin, Ireland)
    • Boston Scientific Corporation (Marlborough, U.S.)
    • BioTelemetry (Malvern, U.S.)
    • iRhythm Technologies, Inc. (San Francisco, U.S.)
    • Medi-Lynx Cardiac Monitoring, LLC. (Plano, U.S.)
    • CamNtech Ltd (Fenstanton, U.K.)
    • ZOLL Medical Corporation (Chelmsford, U.S.)

 

 

Report Scope and Segmentation:

 

  ATTRIBUTE

 

 

  DETAILS

 

 

Study Period

 

 

2017-2028

 

 

Base Year

 

 

2020

 

 

Estimated Year

 

 

2021

 

 

Forecast Period

 

 

2021-2028

 

 

Historical Period

 

 

2017-2019

 

 

Unit

 

 

Value (USD billion)

A

 

Segmentation

 

 

Device Type, Type, Application, End-user, and Region

 

 

By Device type

 

 

    • Holter Monitors
    • Event Monitors
    • Mobile Cardiac Telemetry Monitors

 

 

 

By Type

 

 

    • External
    • Implantable

 

 

 

By Application

 

 

    • Tachycardia
    • Bradycardia
    • Atrial Fibrillation
    • Ventricular Fibrillation
    • Others

 

 

 

By End-user

 

 

    • Hospitals and ASCs
    • Diagnostics Centers and Clinics
    • Others

 

 

 

By Geography

 

 

    • North America (By Device Type, By Type, By Application, By End-user, and By Country)
        • U.S. (By Application)

       

        • Canada (By Application)

       

       

 

    • Europe (By Device Type, By Type, By Application, By End-user, and By Country)
    • U.K. (By Application)

 

    • Germany (By Application)

 

    • France (By Application)

 

    • Italy (By Application)

 

    • Spain (By Application)

 

    • Scandinavia (By Application)

 

    • Rest of Europe (By Application)

 

 

 

    • Asia Pacific (By Device Type, By Type, By Application, By End-user, and By Country)
        • Japan (By Application)

       

        • China (By Application)

       

        • India (By Application)

       

        • Australia (By Application)

       

        • Southeast Asia (By Application)

       

        • Rest of Asia Pacific (By Application)

       

       

 

    • Latin America (By Device Type, By Type, By Application, By End-user, and By Country)
        • Brazil (By Application)

       

        • Mexico (By Application)

       

        • Rest of Latin America (By Application)

       

       

 

    • Middle East & Africa (By Device Type, By Type, By Application, By End-user, and By Country)
        • South Africa (By Application)

       

        • GCC (By Application)

       

        • Rest of Middle East & Africa (By Application)

       

       

 

 

 

By Device type

 

 

    • Holter Monitors
    • Event Monitors
    • Mobile Cardiac Telemetry Monitors

 

 

 

By Type

 

 

    • External
    • Implantable

 

 

 

By Application

 

 

    • Tachycardia
    • Bradycardia
    • Atrial Fibrillation
    • Ventricular Fibrillation
    • Others

 

 

 

By End-user

 

 

    • Hospitals and ASCs
    • Diagnostics Centers and Clinics
    • Others

 

 

 

    • Abbott (Lake Bluff, U.S.)
    • Medtronic (Dublin, Ireland)
    • Boston Scientific Corporation (Marlborough, U.S.)
    • BioTelemetry (Malvern, U.S.)
    • iRhythm Technologies, Inc. (San Francisco, U.S.)
    • Medi-Lynx Cardiac Monitoring, LLC. (Plano, U.S.)
    • CamNtech Ltd (Fenstanton, U.K.)
    • ZOLL Medical Corporation (Chelmsford, U.S.)

 

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF